Purchase Order 36C26126P0546
- Not listed
- The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21) awarded Edwards Lifesciences LLC a $65,000 firm fixed-price purchase order on April 1, 2026, for the restock of transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics. The contract carries no set-aside designation and will be performed in San Francisco, California, with a completion date of June 30, 2026. This purchase order is issued under Edwards Lifesciences LLC's existing...
- The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded Edwards Lifesciences LLC a $65,000 firm fixed-price purchase order on January 15, 2026, for transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetic devices to support the VA Palo Alto Health Care System. This award carries no set-aside designation and represents a restocking procurement executed under the company's existing five-year, $6.5 million indefinite delivery...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 21, awarded Edwards Lifesciences LLC a $65,000 firm fixed-price purchase order on January 29, 2026, for transcatheter aortic valve replacement (TAVR) surgical implants restocking. The contract, with performance completion by April 28, 2026, supports the VA Palo Alto Health Care System's cardiac surgical program by replenishing inventory of specialized cardiovascular devices. This award carries no set-aside designation...
- Edwards Lifesciences LLC received a $32.5K firm fixed-price purchase order from the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) for transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics restocking. The contract, awarded on February 9, 2026, carries an ultimate completion date of May 8, 2026, with performance taking place at the VA Palo Alto Health Care System in San Francisco, California. No set-aside designation was utilized...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $65,000 firm fixed-price purchase order to Edwards Lifesciences LLC on September 18, 2025, for the restock of transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics. The contract, which is not set-aside designated, will be performed in San Francisco, California, with a completion date of December 17, 2025. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences...
- Edwards Lifesciences LLC was awarded a $65,000 firm fixed-price purchase order by Veterans Integrated Service Network 21 (VISN 21) on October 28, 2025, for the procurement of transcatheter aortic valve replacement (TAVR) surgical implants and prosthetics. The contract is scheduled for completion by January 27, 2026, and will be performed in San Francisco, California. This award was made without a set-aside designation and represents Edwards Lifesciences LLC's continued role as a specialized...
- The U.S. Department of Veterans Affairs, through Veterans Integrated Service Network 21, awarded a $32.5K firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) surgical implants restocking. This contract, awarded December 29, 2025, with an ultimate completion date of March 28, 2026, supports the VA's mission to provide advanced cardiovascular care to veterans at the San Francisco facility. No set-aside designation was utilized for this...
- Edwards Lifesciences LLC has been awarded a $32.5K firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 21 for the restock of transcatheter aortic valve replacement (TAVR) surgical implants. The contract, awarded on December 30, 2025, has an ultimate completion date of March 29, 2026, and will be performed in San Francisco, California. No set-aside designation was used for this procurement, and Edwards Lifesciences LLC serves as both the prime contractor and sole...
- Edwards Lifesciences LLC was awarded a $32,500 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 21 on November 3, 2025, for transcatheter aortic valve replacement (TAVR) surgical implants and prosthetics. The contract, which carries no set-aside designation, is scheduled for completion by February 2, 2026, and will be performed in San Francisco, California. As the sole manufacturer of these specialized cardiovascular devices, Edwards Lifesciences LLC serves as the...
- Edwards Lifesciences LLC received a $32.5K firm fixed-price purchase order from Veterans Integrated Service Network (VISN) 21, funded through the Department of Veterans Affairs, for transcatheter aortic valve replacement (TAVR) surgical implants restock. The contract, awarded on March 26, 2026, with an ultimate completion date of June 25, 2026, will support the VA Palo Alto Health Care System's cardiac surgical programs. This procurement carries no set-aside designation and represents a...
The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21) awarded a $65,000 firm fixed-price purchase order to Edwards Lifesciences LLC for the restock of transcatheter aortic valve replacement (TAVR) surgical implants. The contract, awarded on March 17, 2026, carries an ultimate completion date of June 16, 2026, and will be performed in San Francisco, California. This procurement carries no set-aside designation and reflects the VA's continued reliance on Edwards Lifesciences LLC as a specialized supplier of advanced cardiovascular devices essential to veteran cardiac care. This purchase order operates within the framework of a five-year indefinite delivery contract valued at $6.5 million between VISN 21 and Edwards Lifesciences LLC, effective through December 31, 2030, for surgical implant consignment services to the VA Palo Alto Health Care System. The consignment model allows VISN 21 to maintain inventory of Edwards Lifesciences' specialized cardiac devices and procure them on an as-needed basis, optimizing inventory management for products with limited shelf-life. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, has established itself as a critical supplier across multiple VA service networks, with particular procurement concentration in VISN 21 and other high-volume cardiac surgery centers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $65.0k | 3/16/26 |